BAADesign enables the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Sep-2025 22:11 ET (2-Sep-2025 02:11 GMT/UTC)
Monoclonal antibodies like etesevimab have lost efficacy against Omicron subvariants, necessitating innovative solutions. George Fu Gao's team developed BAADesign, a strategy combining structural analysis, computational design, and experimental validation to restore antibody activity. Using this method, they reengineered etesevimab into CB6-IV, achieving broad-spectrum neutralization against Omicron subvariants.
A new study from Tulane University sheds light on ventilator-induced lung injury, a complication that gained increased attention during the COVID-19 pandemic, which led to a surge in patients requiring mechanical ventilation. The study suggests that repeated collapse and reopening of tiny alveoli—air sacs in the lungs essential for breathing—during mechanical ventilation may cause microscopic tissue damage, playing a key role in ventilator-related injuries that contribute to thousands of deaths annually.